ABI3 and thyroid gland carcinoma: To investigate whether the down-regulation of ABI3 expression in FTC, as compared to FTA, results from hypermethylation of the CpG sites located in the promoter region of ABI3 gene, we focused our analysis of DNA methylation on a region within the promoter (R1) that was methylated in thyroid carcinoma cell lines.